On ECHEMI
Home > Drugs > China National Pharmaceutical Industry Corporation Ltd
China National Pharmaceutical Industry Corporation Ltd
  • Founded in:

    2002-12-30
  • Country:

    China China
  • Address:

    No. 6, Niuhui South 1st Street, Niulanshan Town, Shunyi District, Beijing
  • Tax NO.:

    91110000710930704J
  • Registered Funds:

    230 million yuan
  • Website:

  • Email:

Related Drugs
Aminophene and codeine tablets Ⅰ
Name Description Content CAS NO. Registered Holders
Codeine

Has analgesic effect

More

Has analgesic effect

0
Povidone-iodine suppositories
Each tablet of this product contains 20 mg of the main ingredient, povidone iodine, calculated as available iodine, and the auxiliary material is a water-soluble medicinal matrix.
Name Description Content CAS NO. Registered Holders
Povidone iodine

Disinfectant and preservative, it has a killing effect on various bacteria, bacterial spores, viruses, fungi, etc. After contacting the wound or affected area, it can depolymerize and release the iodine contained in it to exert a bactericidal effect. It is characterized by low irritation to tissues and is suitable for skin and mucous membrane infections.

More

Disinfectant and preservative, it has a killing effect on various bacteria, bacterial spores, viruses, fungi, etc. After contacting the wound or affected area, it can depolymerize and release the iodine contained in it to exert a bactericidal effect. It is characterized by low irritation to tissues and is suitable for skin and mucous membrane infections.

20mg 25655-41-8 34
Compound bismuth subgallate suppository Ⅱ
This product is a compound preparation, each tablet contains 200 mg of bismuth subgallate, 0.03 ml of belladonna fluid extract, and 0.4 mg of epinephrine. The excipients are mixed fatty acid glycerides, sodium pyrosulfite, and sodium sulfite.
Name Description Content CAS NO. Registered Holders
BISMUTH SUBGALLATE

Astringent and hemostatic effect

More

Astringent and hemostatic effect

200mg 99-26-3 3
Extract Belladonna soft liquid and powder

Antispasmodic and analgesic effects

More

Antispasmodic and analgesic effects

0.03ml 0
L(-)-Epinephrine

Vasoconstriction and hemostasis

More

Vasoconstriction and hemostasis

0.4mg 51-43-4 30
naproxen suppository
Main ingredient Generic name Naproxen Chemical name () alpha;-methyl-6-methoxy-2-naphthylacetic acid
Name Description Content CAS NO. Registered Holders
Naproxen

This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins. It is rapidly absorbed after rectal administration, and its plasma protein binding rate is higher than 99%. T1/2 is generally 13 hours. It is metabolized in the liver and excreted through the kidneys. About 95% is excreted in the urine in its original form and its conjugates.

More

This product is a non-steroidal anti-inflammatory drug. Its analgesic, anti-inflammatory and antipyretic effects work by inhibiting the synthesis of prostaglandins. It is rapidly absorbed after rectal administration, and its plasma protein binding rate is higher than 99%. T1/2 is generally 13 hours. It is metabolized in the liver and excreted through the kidneys. About 95% is excreted in the urine in its original form and its conjugates.

22204-53-1 30
Indomethacin suppositories
Indomethacin
Name Description Content CAS NO. Registered Holders
Indometacin

This product is a non-steroidal anti-inflammatory analgesic that has the effect of inhibiting the synthesis of prostaglandins. Its anti-inflammatory, analgesic and antipyretic effects may be related to the inhibition of prostaglandin synthesis. Due to the high incidence of adverse reactions of this product, it is only used clinically for its anti-inflammatory and analgesic effects, and is not used solely as a general antipyretic and analgesic.

More

This product is a non-steroidal anti-inflammatory analgesic that has the effect of inhibiting the synthesis of prostaglandins. Its anti-inflammatory, analgesic and antipyretic effects may be related to the inhibition of prostaglandin synthesis. Due to the high incidence of adverse reactions of this product, it is only used clinically for its anti-inflammatory and analgesic effects, and is not used solely as a general antipyretic and analgesic.

53-86-1 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.